First Trust NYSE Arca Biotechnology Index Fund
241 hedge funds and large institutions have $751M invested in First Trust NYSE Arca Biotechnology Index Fund in 2022 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 63 increasing their positions, 72 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
13% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 72
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
241
Holding in Top 10
4
Calls
$894K
Puts
–
Top Buyers
| 1 | +$19.5M | |
| 2 | +$12.4M | |
| 3 | +$7.02M | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$4.62M |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$3.88M |
Top Sellers
| 1 | -$65.8M | |
| 2 | -$6.95M | |
| 3 | -$4.57M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.02M |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$1.96M |